Article thumbnail

Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2

By Kathleen I. Pritchard, Howard A. Burris, Yoshinori Ito, Hope S. Rugo, Shaker Dakhil, Gabriel N. Hortobagyi, Mario Campone, Tibor Csöszi, José Baselga, Puttisak Puttawibul, Martine Piccart, Daniel Heng, Shinzaburo Noguchi, Vichien Srimuninnimit, Hugues Bourgeois, Antonio Gonzalez Martin, Karen Osborne, Ashok Panneerselvam, Tetiana Taran, Tarek Sahmoud and Michael Gnant
Publisher: Elsevier BV
Year: 2013
DOI identifier: 10.1016/j.clbc.2013.08.011
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doi.org/10.1016/j.clbc... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.